Genetic testing has become one of the fastest-growing categories in medical billing—and one of the most confusing. A 2024 study found that 1 in 4 patients who received genetic testing were hit with a surprise bill, with the average unexpected charge exceeding $1,400. The problem: tests that cost labs $200–$500 to run are routinely billed at $5,000–$10,000, insurance pre-authorization rules are opaque, and bills often come from labs patients have never heard of. This guide explains every type of genetic test, what it should cost, and how to fight back when the bill arrives.
1. Types of genetic tests and what they cost
Not all genetic tests are equal in complexity, cost, or insurance coverage. Understanding the category of test helps you predict what you will owe.
| Test Type | Common Tests | Lab Cost to Run | Typical Billed Amount | Insurance Coverage |
|---|---|---|---|---|
| Carrier screening | Cystic fibrosis, sickle cell, Tay-Sachs panels | $100–$300 | $350–$2,000 | Usually covered for reproductive planning |
| BRCA / hereditary cancer | BRCA1, BRCA2, multi-gene cancer panels | $200–$500 | $300–$5,000 | Covered with qualifying family history |
| Prenatal screening (NIPT) | Cell-free DNA (MaterniT21, Harmony, Panorama) | $150–$400 | $800–$3,000 | Generally covered; age-based criteria at some insurers |
| Pharmacogenomic | CYP2D6, CYP2C19 for drug metabolism | $100–$250 | $250–$2,500 | Inconsistent; often denied as "investigational" |
| Diagnostic (rare disease) | Whole-exome sequencing, whole-genome | $500–$1,500 | $5,000–$10,000+ | Covered after clinical criteria met; step therapy often required |
| Direct-to-consumer | 23andMe, AncestryDNA health reports | $100–$200 | $100–$300 (retail) | Not covered; patient pays retail price |
The gap between what a test costs to run ($100–$500 for most panels) and what labs bill insurance ($2,000–$10,000) is where the profit—and the surprise bills—come from. BillKarma's analysis of genetic testing claims found that 31% of patients who received surprise bills were charged more than 10x the lab's self-pay price. When insurance denies the claim, the lab sends the full billed amount to the patient.
2. Insurance coverage rules for genetic testing
Insurance coverage for genetic testing follows a complex set of medical necessity criteria that vary by insurer, test type, and diagnosis.
BRCA and hereditary cancer testing is covered by most insurers when the patient meets specific family history criteria, such as a first-degree relative with breast cancer diagnosed before age 50 or multiple family members with specific cancers. The U.S. Preventive Services Task Force (USPSTF) gives BRCA screening a "B" rating for women with qualifying risk, which means insurers must cover it with no cost-sharing under the ACA preventive care mandate.
Prenatal screening (NIPT) is generally covered for all pregnancies, though some insurers restrict it to "high-risk" pregnancies (maternal age 35+, abnormal ultrasound findings, or prior affected pregnancy). The ACA preventive care mandate does not explicitly cover NIPT, so coverage varies.
Pharmacogenomic testing has the most inconsistent coverage. Many insurers still classify it as "investigational" or "not medically necessary," despite evidence that it improves drug prescribing outcomes. If your doctor orders pharmacogenomic testing, insist on pre-authorization and be prepared for a potential denial.
Pre-authorization is essential. Never agree to genetic testing without written pre-authorization from your insurer. Verbal assurances from your doctor's office that a test is "covered" are not binding on your insurer. Pre-authorization should come directly from the insurance company.
Use our cost calculator to look up Medicare rates for genetic testing CPT codes and compare against what you were billed. You can also check your facility's billing history in our hospital pricing directory.
3. Why genetic testing surprise bills happen
Genetic testing generates more surprise bills than almost any other category of medical care. Here is why:
Out-of-network labs. Your doctor may be in-network, but the lab they send your sample to is not. Specialty genetic testing labs like Myriad Genetics, Invitae, Ambry Genetics, and Natera each have different network agreements. Your doctor's office often does not verify the lab's network status before ordering the test.
Post-service claim denial. Even with pre-authorization, insurers can deny claims after the test is performed if they determine the coding was incorrect, the criteria were not fully documented, or the test results do not align with the stated indication.
Balance billing by labs. If the lab is out-of-network, it may bill the insurance company its full rate, receive a partial payment, and send the remaining balance to you. The No Surprises Act does not cover lab services ordered in an outpatient setting in most cases, leaving you exposed.
Unbundled testing. Some labs bill individual genes or analytes separately instead of as a panel, inflating the total charge. A 30-gene carrier screening panel that should be billed under a single CPT code (81443) might be billed as 30 individual gene tests, each at $200–$500.
4. A real genetic testing bill, annotated
Here is a bill received by a patient who was told her BRCA test would be covered by insurance. The doctor ordered a multi-gene hereditary cancer panel.
The insurer paid $2,100 toward the BRCA analysis (81162) and denied the other two genetic codes as "not pre-authorized." The lab sent the patient a bill for $5,700.
Case study: $7,800 BRCA test bill reduced to $250
A 42-year-old woman with a family history of breast cancer (mother diagnosed at 47, maternal aunt at 52) was referred for BRCA testing by her gynecologist. Her doctor's office told her the test was "covered by insurance." The lab billed $7,800 for BRCA full sequencing (81162) plus a 20-gene supplemental panel (81479). Her insurer covered $2,400 for the BRCA analysis but denied the supplemental panel as "investigational."
The lab sent her a bill for $5,400. She called the lab and asked for their self-pay price. They offered $250 for the entire test—a price the lab routinely charges uninsured patients. She asked the lab to write off the insurance-denied amount and bill her at the self-pay rate. They agreed. Final cost: $250 instead of $5,400.
Lesson: Always ask labs for their self-pay or cash price. Many genetic testing labs charge $250–$500 cash for tests they bill insurance $5,000–$10,000. If your insurance denies the claim, the cash price is almost always available to you.
5. How to dispute a genetic testing bill
Step 1: Request an itemized bill. Get the CPT codes, billed amounts, and the lab's name and address. Upload it to BillKarma for an instant comparison against Medicare rates.
Step 2: Verify pre-authorization. Check whether pre-authorization was obtained for each CPT code on the bill. If the lab added tests beyond what was pre-authorized, those charges may be the lab's responsibility, not yours.
Step 3: Ask for the cash price. Call the lab directly and ask: "What is your self-pay price for this test?" The answer is almost always 80–95% lower than the billed amount. Many labs have formal financial assistance or self-pay pricing programs.
Step 4: File an insurance appeal. If the test was pre-authorized and then denied, appeal with a copy of the pre-authorization, the letter of medical necessity, and your doctor's clinical notes. Cite ACA preventive care requirements if the test qualifies (BRCA screening with qualifying risk factors).
Step 5: File a complaint if necessary. If the lab engaged in deceptive billing (told you the test was covered, failed to obtain pre-authorization, or billed at inflated rates), file a complaint with your state's attorney general consumer protection division and your state insurance commissioner.
Case study: $3,200 prenatal screening bill eliminated through insurer appeal
A 33-year-old pregnant woman received a bill for $3,200 from Natera for a Panorama NIPT (prenatal cell-free DNA screening). Her OB's office had ordered the test during a routine prenatal visit. Her insurer denied the claim because she was under 35 and classified as "low risk."
She filed an appeal citing the American College of Obstetricians and Gynecologists (ACOG) 2020 guideline recommending NIPT be offered to all pregnant patients regardless of age. She included her OB's letter supporting the test as standard of care. The insurer overturned the denial and covered the test at the in-network rate. She also contacted Natera, which confirmed it would accept the insurance payment as payment in full with no balance billing. Final patient cost: $0.
Lesson: For NIPT bills, cite ACOG guidelines in your appeal. The standard of care has shifted to recommending NIPT for all pregnancies, and many insurers have not updated their age-based restrictions.
Case study: $5,600 prenatal genetic screening reclassified as preventive—covered at 100%
A 29-year-old pregnant woman received a bill for $5,600 from a genetics lab after her OB ordered a comprehensive prenatal screening panel that included carrier screening and an expanded NIPT. Her insurer processed the claim as diagnostic testing, applying her $3,000 deductible and 30% coinsurance, leaving her with $4,780 in patient responsibility.
She filed an appeal arguing that the tests were preventive in nature—ordered as part of routine prenatal care with no prior indication of a genetic abnormality. She included ACOG guidelines recommending carrier screening and NIPT for all pregnancies, her OB’s letter confirming the tests were ordered as standard preventive screening, and the ACA requirement that insurers cover USPSTF-recommended preventive services at no cost. The insurer reclassified the claim as preventive care and covered the full $5,600 with zero patient cost-sharing. Savings: $4,780.
Lesson: If prenatal genetic screening is coded as diagnostic rather than preventive, appeal with ACOG guidelines and ACA preventive care rules. The coding distinction alone can mean the difference between $0 and thousands out of pocket.
6. Your rights: GINA and the No Surprises Act
Genetic Information Nondiscrimination Act (GINA). GINA protects you from discrimination by health insurers and employers based on genetic test results. Your health insurer cannot deny you coverage, raise your premiums, or impose pre-existing condition exclusions based on genetic information. Your employer cannot use genetic information in hiring, firing, or promotion decisions. However, GINA does not cover life insurance, disability insurance, or long-term care insurance.
No Surprises Act. The No Surprises Act provides limited protection for genetic testing. If you receive genetic testing during an emergency visit at an out-of-network facility, the Act applies. However, for outpatient lab services (which is how most genetic testing occurs), protections are more limited. If your doctor ordered the test and you were not informed the lab was out-of-network, you may still have grounds for a dispute under state consumer protection laws. Learn more in our No Surprises Act guide.
ACA preventive care mandate. The ACA requires insurers to cover USPSTF-recommended preventive services with no cost-sharing. BRCA screening for women with qualifying risk factors is covered under this mandate. If your insurer charged you a copay or coinsurance for BRCA screening that meets USPSTF criteria, you have the right to a refund. Read our preventive care billing guide for more details.
| Dispute Strategy | When to Use It | Typical Savings |
|---|---|---|
| Ask for lab self-pay price | Insurance denied the claim; lab billed you full rate | 80–95% off billed amount |
| Appeal with pre-auth documentation | Test was pre-authorized but claim was denied | Full coverage restored |
| Cite USPSTF/ACA preventive mandate | BRCA screening denied or subject to cost-sharing | 100% coverage, $0 patient cost |
| Cite ACOG guidelines for NIPT | Prenatal screening denied due to age under 35 | Full coverage of $800–$3,000 test |
| File state consumer complaint | Lab failed to disclose out-of-network status or costs | Bill reduced or waived |
Frequently asked questions
How much do genetic tests cost without insurance?
Costs range from $250 for single-gene panels to $10,000+ for whole-exome sequencing. Most common tests (BRCA, carrier screening, NIPT) have self-pay prices of $250–$500 when you ask the lab directly—dramatically less than what they bill insurance.
Does insurance cover genetic testing?
It depends on the test and your diagnosis. BRCA testing with qualifying family history is usually covered. Prenatal screening is generally covered. Pharmacogenomic testing has inconsistent coverage. Always get written pre-authorization before any genetic test.
What is the difference between pre-authorization and a guarantee of payment?
Pre-authorization means your insurer agrees the test is medically necessary and will process the claim. It is not a guarantee they will pay. Claims can still be denied after testing for coding errors or documentation gaps. Get pre-authorization in writing and keep a copy.
Can I dispute a surprise genetic testing bill?
Yes. Ask the lab for their self-pay price (usually 80–95% lower than the billed amount). If your insurer denied a pre-authorized test, appeal with the pre-authorization letter and letter of medical necessity. Upload your bill to BillKarma to identify the specific overcharges.
Why did I get a bill from a lab I have never heard of?
Your doctor likely sent your sample to a specialty reference lab that is out-of-network with your insurer. Always ask your doctor which lab will perform the test and verify that lab's network status with your insurer before agreeing to testing.
What are my rights under GINA?
GINA prevents health insurers from denying coverage or raising premiums based on genetic test results. It also prevents employer discrimination. However, GINA does not apply to life insurance, disability insurance, or long-term care insurance.
Sources
- NIH National Human Genome Research Institute: Genetic Discrimination and GINA
- USPSTF: BRCA-Related Cancer Risk Assessment and Genetic Testing Recommendation
- ACOG: Cell-Free DNA Screening for Fetal Aneuploidy
- CMS Clinical Laboratory Fee Schedule (2026)
- CMS: No Surprises Act Implementation
- American Journal of Managed Care: Genetic Testing Surprise Billing Analysis (2024)